Stocks to focus on - March 2nd week

Key Company Updates

reported consolidated crude steel production of 24.07 lakh tonnes for February 2025, up 12% from 21.50 lakh tonnes in the same month last year. Capacity utilization at its Indian operations stood at 93.5% for the month. 's subsidiary, ONGC Petro Additions (OPaL), has received a letter from the Development Commissioner, Dahej Special Economic Zone, granting final exit to OPaL from the Dahej SEZ. has inked a memorandum of understanding (MoU) with the Indian Institute of Technology, Hyderabad, for establishing a Centre of Clean Coal Energy and Net Zero (CLEANZ) at Hyderabad. Significant Deals and Agreements Renewable Energy, a subsidiary of Tata Power, has signed an MoU with the Government of Andhra Pradesh to develop up to 7,000 MW of renewable energy projects, including solar, wind, and hybrid projects with or without storage solutions. The estimated investment in these projects stands at up to Rs 49,000 crore. has received a work order worth Rs 28.29 crore from Northern Railway and another order worth Rs 47.50 crore from East Central Railway. of India has signed an MoU with The Energy and Resources Institute (TERI) for setting up a Centre of Excellence (COE) for green and sustainable logistics at TERI. has launched Rivaroxaban tablets (2.5 mg) in the United States after final approval of its Abbreviated New Drug Application from the USFDA. The drug is bioequivalent to Xarelto tablets by Janssen Pharmaceuticals and is used to reduce the risk of major cardiovascular events. 's subsidiary, Biocon Biologics, announced the successful results of a pivotal Phase 3 study comparing Yesintek (Biocon Biologics' biosimilar to Ustekinumab) with the reference product Stelara (Ustekinumab) in adult patients with moderate to severe chronic plaque psoriasis. Note : Make sure to follow risk management and position sizing at all times